Effect of intravenous iron (ferric derisomaltose) on haemoglobin and clinical events according to age in patients with heart failure and iron deficiency in a randomised trial (ironman)

被引:0
|
作者
Squire, Iain [1 ]
Cowburn, Peter [2 ]
Lang, Ninian [3 ]
Critoph, Chris [4 ]
Schiff, Rebekah [5 ]
Szwejkowski, Ben [6 ]
Petrie, Mark [7 ]
Kalra, Paul [8 ]
Ford, Ian [7 ]
Ray, Robin [9 ]
Donnelly, Patrick [10 ]
Clelland, John G. F. [7 ]
Robertson, Michele [7 ]
Thomson, Elizabeth [7 ]
Banerjee, Prithwish [11 ]
Nageh, Thuraia [12 ]
机构
[1] Glenfield Hosp, Dept Cardiovasc Sci, Cardiovasc Res Ctr, Leicester, Leics, England
[2] Univ Hosp Southampton, Southampton, Hants, England
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] Univ Hosp Bournemouth, Bournemouth, Dorset, England
[5] Guys & St Thomas NHS Trust, London, England
[6] Ninewells Hosp & Med Sch, Dundee, Scotland
[7] Univ Glasgow, Glasgow, Lanark, Scotland
[8] Portsmouth Hosp Univ NHS Trust, Portsmouth, Hants, England
[9] St Georges Hosp NHS Trust, London, England
[10] Univ HF Leicester, Leicester, Leics, England
[11] Univ Hosp Coventry & Warwickshire, Coventry, W Midlands, England
[12] Mid & South Essex NHS Trust, Southend On Sea, Essex, England
关键词
IRONMAN; HEART FAILURE; IRON DEFICIENCY;
D O I
10.1136/heartjnl-2023-BCS.134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
134
引用
收藏
页码:A154 / A155
页数:2
相关论文
共 50 条
  • [31] Budget impact of intravenous ferric carboxymaltose in patients with chronic heart failure and iron deficiency in France
    Bourguignon, Sandrine
    Faller, Mathilde
    Champs, Francois-Olivier
    Moutier, Helene
    Levesque, Karine
    Caranhac, Gilbert
    Cohen-Solal, Alain
    ESC HEART FAILURE, 2019, 6 (03): : 559 - 569
  • [32] Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials
    Graham, Fraser J.
    Pellicori, Pierpaolo
    Ford, Ian
    Petrie, Mark C.
    Kalra, Paul R.
    Cleland, John G. F.
    CLINICAL RESEARCH IN CARDIOLOGY, 2021, 110 (08) : 1299 - 1307
  • [33] Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials
    Fraser J. Graham
    Pierpaolo Pellicori
    Ian Ford
    Mark C. Petrie
    Paul R. Kalra
    John G. F. Cleland
    Clinical Research in Cardiology, 2021, 110 : 1299 - 1307
  • [34] The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron De ficiency, and Heart Failure With Reduced Ejection Fraction
    Ray, Robin
    Ford, Ian
    Cleland, John G. F.
    Graham, Fraser
    Ahmed, Fozia Z.
    Al-Mohammad, Abdallah
    Cowburn, Peter J.
    Critoph, Chris
    Kalra, Philip A.
    Lane, Rebecca E.
    Ludman, Andrew
    Pellicori, Pierpaolo
    Petrie, Mark C.
    Robertson, Michelle
    Seed, Alison
    Squire, Iain
    Kalra, Paul R.
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (05) : 682 - 690
  • [35] EFFICACY OF INTRAVENOUS FERRIC CARBOXYMALTOSE IN PATIENTS WITH IRON DEFICIENCY FOLLOWING ACUTE HEART FAILURE, ACCORDING TO BASELINE EGFR: A SUBGROUP ANALYSIS OF THE AFFIRM-AHF TRIAL
    Macdougall, Iain
    Jankowska, Ewa A.
    Metra, Marco
    Filippatos, Gerasimos
    Kirwan, Bridget-Anne
    Van der Meer, Peter
    Ruschitzka, Frank
    Fabien, Vincent
    Waechter, Sandra
    Butler, Javed
    Anker, Stefan D.
    Ponikowski, Piotr
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [36] Effect of intravenous iron sucrose on exercise tolerance in anemic and non-anemic patients with symptomatic chronic heart failure and iron deficiency: A randomised, controlled, observer-blinded trial (FERRIC-HF)
    Okonko, Darlington O.
    Grzeslo, Agnieszka
    Witkowski, Tomasz
    Mandal, Amit K.
    Slater, Robert M.
    Foldes, Gabor
    Banasiak, Waldemar
    Missouris, Constantinos G.
    Poole-Wilson, Philip A.
    Anker, Stefan D.
    Ponikowski, Piotr
    CIRCULATION, 2006, 114 (18) : 407 - 407
  • [37] Intravenous iron in patients with iron deficiency and heart failure: a review of modern evidence
    Gale, Stormi E.
    Willeford, Andrew
    Sandquist, Katherine
    Watson, Kristin
    CURRENT OPINION IN CARDIOLOGY, 2024, 39 (03) : 178 - 187
  • [38] A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status
    S. Bhandari
    V. Allgar
    A. Lamplugh
    I. Macdougall
    P. A. Kalra
    BMC Nephrology, 22
  • [39] Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
    van Veldhuisen, Dirk J.
    Ponikowski, Piotr
    van der Meer, Peter
    Metra, Marco
    Bohm, Michael
    Doletsky, Artem
    Voors, Adriaan A.
    Macdougall, Iain C.
    Anker, Stefan D.
    Roubert, Bernard
    Zakin, Lorraine
    Cohen-Solal, Alain
    CIRCULATION, 2017, 136 (15) : 1374 - +
  • [40] THE DIFFERENTIAL EFFECT OF THIRD-GENERATION INTRAVENOUS IRON PREPARATIONS (FERRIC CARBOXYMALTOSE, FERRIC DERISOMALTOSE) ON CARDIOVASCULAR PARAMETERS IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD AND IRON DEFICIENCY ANAEMIA
    Kassianides, Xenophon
    Bhandari, Sunil
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I385 - I385